Originally published February 19 2006
Study confirms that two antivirals are ineffective against the flu
by Mike Adams, the Health Ranger, NaturalNews Editor
Centers for Disease Control and Prevention Director Julie Gerberding talks about the findings of a study that showed the antiviral pills amantadine and rimantadine were ineffective in treating flu.
U.S. doctors should stop using two medicines to treat this season's influenza because the dominant strain has become resistant to the drugs and they are unlikely to work, health officials said on Saturday.
The alert about antiviral pills amantadine and rimantadine applies to the seasonal influenza, not the H5N1 avian flu strain that experts fear could mutate and cause a global pandemic.
Tests of 120 samples of the H3N2 flu strain -- the major one causing flu illness in the United States -- showed it was resistant to amantadine and rimantadine in 91 percent of cases, Centers for Disease Control and Prevention Director Julie Gerberding said.
Only 11 percent of cases were resistant to the two drugs during the last flu season.
"Physicians should not use amantadine and rimantadine to prevent flu or to treat patients suspected of having influenza because the drugs will not be effective," Gerberding said at a news conference.
Doctors instead should prescribe either of two newer medicines, Tamiflu or Relenza, which still fight the strain, she said.
The older medicines are cheaper and sometimes prescribed to nursing home patients during a flu outbreak to prevent infection.
"We don't think this (new advice) is going to affect a large number of patients because not many patients are typically treated with amantadine and rimantadine," Gerberding said.
It was unclear whether the flu virus spontaneously mutated or if something else caused the spike in resistance, Gerberding said.
Some experts think over-the-counter sales of the drugs overseas may have increased exposure enough for the virus to adapt and evade the medicines.
Flu cases are now widespread in seven U.S. states, mostly in the South and Southwest regions, Gerberding said, adding it was too early to say if this year's outbreak had peaked.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml